MentionFox
Home › Who owns › Helus Pharma Inc.
Owners, funding and legal record

Who owns Helus Pharma Inc.? Owners, funding and legal record

Before you sign with, sell to or invest in Helus Pharma Inc.

MentionFox check on Helus Pharma Inc.: no red flags found in 21 sources (checked 14 November 2026). mentionfox.com/c/who-owns/helus-pharma

Check Helus Pharma Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Helus Pharma Inc.?

Helus Pharma Inc. is a publicly traded company (Nasdaq: HELP). Paul Glavine, the executive officer and a director, reports 5.8% on Schedule 13D, the largest active stake (Schedule 13D, filed 2026-09-09).

As of November 14, 2026, Helus Pharma Inc. is a publicly traded company (Nasdaq: HELP). The largest holder reporting an active stake on Schedule 13D is Paul Glavine, the executive officer and a director, at 5.8%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Founder or officer holdings: Eric So, the executive officer and a director (5.8%) (Schedule 13D, September 9, 2026).

Sirenia Capital Management LP also filed stake reports on 19 other companies ↓

Is this your company?

About to sign with, pay or invest in Helus Pharma Inc.? See the free Snapshot first.

Watch Helus Pharma Inc.

Free to see. No signup.

Is Helus Pharma Inc. a real, registered company?

Before you sign or pay

Who are Helus Pharma Inc.'s owners and officers?

Helus Pharma Inc.: industry Pharmaceutical Preparations (Schedule 13G/A, 2026-11-12).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13G/A, 2026-11-12Millennium Management LLC1.4%
Schedule 13G/A, 2026-11-12Adage Capital Management, L.P.7.48%
Schedule 13D, 2026-09-09Glavine Paul5.8%
Schedule 13D, 2026-09-09So Eric H. L.5.8%
Schedule 13G/A, 2026-08-14Sirenia Capital Management LP4.8%
Schedule 13G, 2026-08-12Adage Capital Management, L.P.5.29%
Schedule 13G, 2026-05-15Sirenia Capital Management LP7.2%
Schedule 13G/A, 2026-05-15Point72 Asset Management, L.P.1.4%
Schedule 13G/A, 2026-04-22Millennium Management LLC5.7%
Schedule 13G, 2026-04-10Millennium Management LLC5%
Schedule 13G, 2026-03-26Millennium Management LLC4.8%
Schedule 13G/A, 2026-02-17Tang Capital Management, LLC0%

Questions about who owns Helus Pharma Inc.

Who owns Helus Pharma Inc.?

On this page, 3 holders' latest ownership filings report 5% or more of Helus Pharma Inc.: Adage Capital Management, L.P. (7.48%, Schedule 13G/A, filed 2026-11-12), Glavine Paul (5.8%, Schedule 13D, filed 2026-09-09) and So Eric H. L. (5.8%, Schedule 13D, filed 2026-09-09).

Who are the largest shareholders of Helus Pharma Inc.?

By the share each holder's latest filing reports, the largest holders of Helus Pharma Inc. on this page are Adage Capital Management, L.P. (7.48%), Glavine Paul (5.8%) and So Eric H. L. (5.8%).

When did Adage Capital Management, L.P. buy into Helus Pharma Inc.?

The filings give report dates, not purchase dates. The earliest filing from Adage Capital Management, L.P. on this page is the Schedule 13G, filed 2026-08-12, reporting 5.29%; its latest, Schedule 13G/A filed 2026-11-12, reports 7.48%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Helus Pharma Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Helus Pharma Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Helus Pharma Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    26 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Helus Pharma Inc. shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares outstanding: 21,601,208 as of 2025-03-31, from the company's latest SEC cover page.

How much has Helus Pharma Inc. raised?

Keep reading

More on Helus Pharma Inc. and the records around it.

Helus Pharma Inc. elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/helus-pharma
Last updated 2026-11-14
Who owns Helus Pharma? Paul Glavine 5.8% (Nasdaq: HELP). MentionFox, 2026-11-14. https://mentionfox.com/who-owns/helus-pharma